Navigation Links
9-PCV vaccine found to be helpful in invasive Pneumonococcal infection

Randomized double blind placebo controlled trial was done by Felicity cutts and colleagues in Gambia on the efficacy of // a Nine Valent Pneumococcal Conjugate Vaccine (9-PCV) against radiologically confirmed pneumonia and invasive pneumococcal disesase in children immunized before 12 months of age.

The vaccine was found to reduce the incidence of vaccine type invasive pneumococcal disease by 77%, all serotype invasive Pneumococcal disease by 50%, all the hospital admissions by 15% and overall child mortality by 16%.

The 9-PCV trial reports the higher reduction in the incidence of radiological pneumonia than California and South African studies. The 9-PCV vaccines are used to help the fourth UN Millennium Development Goal in reducing the childhood mortality in developing countries. The evidence for efficacy of the vaccine in all hospital admissions is high.

Chest radiograph has shown high efficacy of the 9-PCV vaccines against pneumonia. The vaccine can also be used as an epidemiological tool to determine the amount of pneumonia due to Pneumococcus. Vaccine efficacy is detected by comparing the percentage reduction of disease incidence in a vaccinated group compared with an unvaccinated group.

In this study the scientists used WHO pneumonia case management algorithm for identifying clinical pneumonia and also WHO radiology standardized guidelines for reading chest radiographs. , Placebo, vaccine trial, nine valent pneumococcal conjugate vaccine, 9PCV, infection, pneumonia, disease, children, serotype, trial report, chest radiograph, WHO.
'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2017)... (PRWEB) , ... April 30, 2017 , ... PracticeMatch, a ... increase in projected attendance for this year’s physician career fairs, with this year’s RSVPs ... complete schedule for the 2017 calendar year of national physician career fairs is located ...
(Date:4/29/2017)... S.C. (PRWEB) , ... April ... ... Southeast’s leading software and web development company, today announced the launch of ... DonorBridge is a solution combining decades of software innovation and industry expertise ...
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of dynamic transitions ... the next without having to set a single keyframe in Final Cut Pro ... video production. , TransDark features dynamic transitions that momentarily splits the RGB layers of ...
(Date:4/29/2017)... ... April 29, 2017 , ... Sterling Global Products ... fine retailers selling biodegradable, hanging flushable wipes dispensers and/or 42 count refill packs ... in San Antonio, Texas, operates more than 350 stores throughout Texas and expanding ...
(Date:4/29/2017)... ... April 29, 2017 , ... ... and recognize the positive impact veterinarians have on animal health and welfare as ... Organization for Animal Health (OIE) choose a theme each year and this year ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... Halo Labs announces the launch of a ... called the Horizon at PEGS 2017 in ... analyzes sub visible particulate matter in biopharmaceutical samples to ... early as candidate selection and pre-formulation. Halo ... organization Elion Labs for system validation. "We ...
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
Breaking Medicine Technology: